<?xml version="1.0" encoding="UTF-8"?>
<fig id="F0003" orientation="portrait" position="float">
 <label>FIGURE 3</label>
 <caption>
  <p>Kaplan–Meier survival curves of deaths to 5 years by baseline CD4 count in (a) Johannesburg and (b) Mopani. Deaths by year of antiretroviral therapy initiation among clients with baseline CD4 counts &lt; 200 cells/mm
   <sup>3</sup> in (c) Johannesburg and (d) Mopani. Deaths by year of antiretroviral therapy initiation among clients with baseline CD4 counts &lt; 200 cells/mm
   <sup>3</sup> where years have been grouped according to the timing of drug changes in the South African guidelines in (e) Johannesburg and (f) Mopani (2004–2009: single formulation regimens including stavudine; 2010–2012: single formulation regimens including tenofovir; 2013–2017: fixed-dose combination).
  </p>
 </caption>
 <graphic xlink:href="HIVMED-20-963-g003" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
